Related references
Note: Only part of the references are listed.Serum Neuron-specific Enolase Levels in Preterm and Term Newborns and in Infants 1-3 Months of Age
Aslihan Abbasoglu et al.
PEDIATRICS AND NEONATOLOGY (2015)
Choice of tumour markers in patients with neuroendocrine tumours is dependent on the histological grade. A marker study of Chromogranin A, Neuron specific enolase, Progastrin-releasing peptide and cytokeratin fragments
Catharina M. Korse et al.
EUROPEAN JOURNAL OF CANCER (2012)
Prognostic value of ferritin, neuron-specific enolase, lactate dehydrogenase, and urinary and plasmatic catecholamine metabolites in children with neuroblastoma
Giuliana Cangemi et al.
ONCOTARGETS AND THERAPY (2012)
Circulating biomarkers in gastroenteropancreatic neuroendocrine tumours
Kjell Oberg
ENDOCRINE-RELATED CANCER (2011)
Chromogranin A-Biological Function and Clinical Utility in Neuro Endocrine Tumor Disease
Irvin M. Modlin et al.
ANNALS OF SURGICAL ONCOLOGY (2010)
The International Neuroblastoma Risk Group (INRG) Classification System: An INRG Task Force Report
Susan L. Cohn et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Elevated Plasma Chromogranin A Is the First Indication of Recurrence in Radically Operated Midgut Carcinoid Tumors
Staffan Welin et al.
NEUROENDOCRINOLOGY (2009)
Neuroblastoma: A single institution's experience with 128 children and an evaluation of clinical and biological prognostic factors
L Lau
PEDIATRIC HEMATOLOGY AND ONCOLOGY (2002)
Chromogranin A, an on/off switch controlling dense-core secretory granule biogenesis
T Kim et al.
CELL (2001)
Share Paper
